Acucela Inc. secured an exclusive option to acquire EyeMedics LLC's proprietary retinal technology for the treatment of certain eye diseases.
While terms of the agreement were not disclosed, Acucela, a Kubota Pharmaceutical Holdings Co. Ltd. subsidiary, noted that the option was acquired under a research and development agreement with the company.